Lunai Bioworks Inc. (LNAI)
Last updated: 2026-10-21 10:24:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Lunai Bioworks Inc. (LNAI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.53, with a market capitalization of $2.14M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.46 to $13.28. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$2.14M | |
$0.51 | |
$13.28 | |
$0.46 | |
$0.52 | |
2.76K | |
204.13K | |
-- | |
$13.28 | |
$0.46 | |
-- | |
-- |
Lunai Bioworks Inc. (LNAI) Pre-Market Stock Price
Lunai Bioworks Inc. (LNAI) is trading at $0.53 in pre-market trading as of 2026-10-21 10:07:00, up 2.72% ($0.01) from the previous close of $0.52
Pre-market trading shows how investors are pricing LNAI before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Lunai Bioworks Inc. (LNAI) 7-Day Stock Price Change
Over the past seven days, Lunai Bioworks Inc. (LNAI) moved from $1.11 to $0.53, representing a decline of 52.34% ($0.58).
The stock traded between $0.46 and $1.29 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 108.39 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
LNAI 52-Week Price Position
Position in Range: 0.5%
LNAI is currently trading at $0.53, placing it 0.5% of the way from its 52-week low of $0.46 to its 52-week high of $13.28. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Lunai Bioworks Inc. (LNAI)?
Lunai Bioworks Inc is an AI-driven biotechnology company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or lifelong cancer remission in some of the deadliest cancers. The Group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. Its reportable segments are BioSymetrics, which derives the maximum revenue, and RENB. Geographically, the Group operates in the United States and Canada.
Lunai Bioworks Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 12 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Lunai Bioworks Inc. (LNAI) Stock on MEXC
Eligible investors can buy real shares of Lunai Bioworks Inc. (LNAI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Lunai Bioworks Inc. (LNAI) stock price today?
2.Is LNAI stock going up or down today?
3.What is LNAI pre-market price?
4.What is LNAI after-hours price?
5.Is LNAI stock trading now?
6.Where does LNAI sit relative to its 52-week high and low?
7.What sector is Lunai Bioworks Inc. in?
8.What is Lunai Bioworks Inc.'s market capitalization and where is it listed?
9.How is LNAI valued in terms of P/E ratio and EPS?
10.Does Lunai Bioworks Inc. pay a dividend?
Explore More US Stocks
Search Stocks
LNAI Stock Calculator
Estimate the value between LNAI shares and USD.
LNAI Shares to USD
1.00 LNAI shares = 0.529 USD
Calculations are estimates based on the latest available price and are for reference only.



